Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
about
Norepinephrine and stimulant addictionThe role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.Anti-relapse medications: preclinical models for drug addiction treatment.Meta-analysis of depression and substance use and impairment among cocaine users.Cocaine Dependence Treatment Data: Methods for Measurement Error Problems With Predictors Derived From Stationary Stochastic Processes.Cognitive impairment in acute cocaine withdrawal.Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.New medications for the treatment of cocaine dependence.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Pharmacotherapy of addictions.Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.Effects of endogenous and exogenous progesterone on emotional intelligence in cocaine-dependent men and women who also abuse alcohol.Differential modulation of cocaine's discriminative cue by repeated and variable stress exposure: relation to monoamine transporter levelsβ-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for β1 and β2 adrenergic receptors.Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy.Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.Emerging pharmacological strategies in the fight against cocaine addiction.Reduction of extinction and reinstatement of cocaine seeking by wheel running in female rats.Neurobiological dissociation of retrieval and reconsolidation of cocaine-associated memoryIncreased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility.Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety.A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans.Treatment outcome predictors for cocaine dependence.Evidence for beta1-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal.Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward.Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysisGuanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-makingSex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesisEvaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) studyHeterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers.Inhibition of hippocampal β-adrenergic receptors impairs retrieval but not reconsolidation of cocaine-associated memory and prevents subsequent reinstatementImpact of gender on corticotropin-releasing factor and noradrenergic sensitivity in cocaine use disorder.Footshock stress potentiates cue-induced cocaine-seeking in an animal model of relapse.Modeling relapse in animals.Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors
P2860
Q24656833-B7BB04CE-AF4E-4B77-AE86-1D903AC4B51FQ33598487-01B2CB5F-8620-45D4-BAEB-8C24FDBDB1EDQ33719351-5851BD50-9144-4A27-9FAE-AAAF6E69DF95Q33927470-7F93AF57-4A8C-4472-92C3-BA72DAB366B0Q34012500-58E854DA-7464-429E-AD86-7C1E8473F5D7Q34044792-26A87CA6-ABF9-46C0-A6C6-C34D537850BBQ34049459-28F5EC87-46B5-4A35-9E6E-EA025F2074CDQ34130038-AD824209-232B-4B89-99BA-36C22840F3E2Q34152650-B5B360AF-11E9-4817-92A5-D93BE917F065Q34253787-689FF72E-2743-4053-BFA9-F83509D9306DQ34810395-5ABD05F5-B9AA-4F63-A680-A1592F1EE340Q35751195-35A112AC-562B-4E86-9D31-2146300FB656Q35841963-D8A5C356-A05A-445C-B917-A23BF24FEECFQ36024364-1FD07E36-E0AC-4C01-A4AE-5D154FD60FEBQ36105362-18E05809-8F8D-46F1-A435-CC41A420A664Q36161215-0EF49E66-5AAE-4FC6-B29D-4A26C776128EQ36341673-238C674A-50E2-444E-8C73-70EA6AB377C0Q36407408-69FAEC49-4EB2-40D8-B513-F6637087598BQ36557948-41B8D7BF-E516-4AD2-A70C-E30E85C55097Q36588185-202215D6-3EED-43A7-A3EB-E175711282AAQ36678739-FB2F25C9-8C39-4F9E-A940-5ABA5B7C4784Q36688691-F97E01EA-C277-49BB-81E4-B8171E07EB33Q36799851-EEAB49F6-95F2-4026-A69A-1EF9D3DD245CQ36819661-78EABB6F-E20A-4DFE-B663-D36C7F28A89DQ36865270-208ECD11-0750-48C0-8C15-DE3C96F8B636Q36881952-24CEC75A-74E4-4E1D-8550-25B8D42DDA56Q36955320-4DCC633F-8375-428F-B1C3-F19568DA821EQ36959712-503AEA91-36AB-4F0F-AAE2-7D65BD6F400BQ36974518-FB6E3D52-1CA0-4982-A5B2-FC0EEA225558Q37047922-600E5495-605A-42FB-A2B7-EF6477FC4B8AQ37062538-71E1E552-5F48-4E99-AC02-4AD5103923EBQ37247887-3E0CBB6E-B0CB-4FD2-950E-6851B62A84B2Q37292214-374B4C22-DD29-43B8-B8C9-2451DD7D6D1CQ37348795-1781C5CC-2F2D-4744-A23B-EBC49F0BE70EQ37352237-58944356-6543-4FA7-95C8-B4B4E9FAB18AQ37409639-B8A2C70B-1667-46F2-B0E9-4021BB494436Q37432164-4018359D-1C0A-44A0-A086-C2B8D260BD36Q37440258-1832EB5D-6047-480D-9C88-5019B858FC06Q37474405-623D3B92-E9D2-459F-9990-3E67500E9FF5Q37663376-36140AD5-893F-4E58-81FD-6A9568160A9C
P2860
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@en
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@nl
type
label
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@en
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@nl
prefLabel
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@en
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@nl
P2093
P1476
Effectiveness of propranolol f ...... e withdrawal symptom severity.
@en
P2093
Alterman AI
Kampman KM
Mulvaney F
P356
10.1016/S0376-8716(00)00193-9
P577
2001-06-01T00:00:00Z